AlphaCrest Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,592
Closed -$481K 719
2022
Q3
$481K Sell
40,592
-67,964
-63% -$1.03M 0.03% 992
2022
Q2
$1.66M Buy
108,556
+87,122
+406% +$1.57M 0.08% 430
2022
Q1
$453K Buy
21,434
+12,761
+147% +$275K 0.03% 941
2021
Q4
$205K Buy
+8,673
New +$186K 0.01% 1332
2021
Q3
Sell
-82,841
Closed -$1.67M 1328
2021
Q2
$1.67M Sell
82,841
-2,477
-3% -$53K 0.07% 432
2021
Q1
$1.82M Buy
85,318
+55,070
+182% +$1.18M 0.1% 282
2020
Q4
$659K Sell
30,248
-18,702
-38% -$364K 0.05% 497
2020
Q3
$863K Buy
48,950
+23,910
+95% +$445K 0.09% 319
2020
Q2
$471K Buy
25,040
+3,075
+14% +$54.5K 0.08% 412
2020
Q1
$380K Buy
21,965
+10,061
+85% +$210K 0.05% 696
2019
Q4
$251K Buy
+11,904
New +$241K 0.02% 1144

Other funds holding MPT

AlphaCrest Capital Management's MPT Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 40,592 shares — an estimated $481K sold.

AlphaCrest Capital Management first reported a position in MPT in Q4 2019 and held it in 11 quarters. The position peaked at $1.82M in Q1 2021. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 40,592 Medical Properties Trust shares in Q4 2022, an estimated $481K.
  • AlphaCrest Capital Management first reported a position in Medical Properties Trust in Q4 2019 and held it in 11 quarters.
  • AlphaCrest Capital Management's Medical Properties Trust position peaked at $1.82M in Q1 2021.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.